T1	Treatment 92 123	cathepsin K inhibitor, ONO-5334
T2	Treatment 420 451	cathepsin K inhibitor, ONO-5334
T3	Treatment 579 699	doses of 10 to 600 mg once daily and 50 and 300 mg twice daily were evaluated in 15- and 28-day multiple-dosing cohorts.
T4	Treatment 1236 1242	days).
T5	Treatment 1243 1251	ONO-5334
T6	Treatment 1344 1357	with ONO-5334
